Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-08 6:39 pm Sale | 2026-10-06 | 13D | ARRIVENT BIOPHARMA INC AVBP | ORBIMED ADVISORS LLC | 2,875,962 5.800% | -151,366 (-5.00%) | Filing History |
| 2026-10-02 5:36 pm Purchase | 2026-09-28 | 13D | ADARX PHARMACEUTICALS INC ADRX | ORBIMED ADVISORS LLC | 14,913,764 14.000% | 14,913,764 (New Position) | Filing History |
| 2026-09-25 5:11 pm Purchase | 2026-09-21 | 13D | ELECTRA THERAPEUTICS INC ETRA | ORBIMED ADVISORS LLC | 6,885,170 11.000% | 6,885,170 (New Position) | Filing History |
| 2026-09-10 5:07 pm Unchanged | 2026-09-08 | 13D | BRAVEHEART BIO INC BRVE | ORBIMED ADVISORS LLC | 12,175,159 13.500% | 0 (Unchanged) | Filing History |
| 2026-08-18 4:59 pm Purchase | 2026-08-07 | 13D | BRAVEHEART BIO INC BRVE | ORBIMED ADVISORS LLC | 12,175,159 17.200% | 12,175,159 (New Position) | Filing History |
| 2026-08-18 4:53 pm Purchase | 2026-08-10 | 13D | BLOSSOMHILL THERAPEUTICS INC C BLSM | ORBIMED ADVISORS LLC | 2,714,279 8.900% | 2,714,279 (New Position) | Filing History |
| 2026-08-14 5:57 pm Sale | 2026-06-30 | 13G | WHITEHAWK THERAPEUTICS, INC. C WHWK | ORBIMED ADVISORS LLC | 3,934,296 7.300% | -231,704 (-5.56%) | Filing History |
| 2026-08-14 5:49 pm Sale | 2026-06-30 | 13G | VISTAGEN THERAPEUTICS INC VTGN | ORBIMED ADVISORS LLC | 0 0.000% | -1,639,700 (Position Closed) | Filing History |
| 2026-08-14 5:45 pm Purchase | 2026-06-30 | 13G | SPRUCE BIOSCIENCES INC SPRB | ORBIMED ADVISORS LLC | 132,200 4.800% | 132,200 (New Position) | Filing History |
| 2026-08-14 5:40 pm Sale | 2026-06-30 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 1,505,125 4.400% | -591,402 (-28.21%) | Filing History |
| 2026-08-14 5:36 pm Purchase | 2026-06-30 | 13G | LEXEO THERAPEUTICS INC LXEO | ORBIMED ADVISORS LLC | 3,203,050 4.100% | 3,203,050 (New Position) | Filing History |
| 2026-08-14 5:31 pm Purchase | 2026-06-30 | 13G | IMMUNIC INC IMUX | ORBIMED ADVISORS LLC | 756,860 5.300% | 756,860 (New Position) | Filing History |
| 2026-08-14 5:26 pm Purchase | 2026-06-30 | 13G | FORTE BIOSCIENCES INC FBRX | ORBIMED ADVISORS LLC | 1,264,980 6.200% | 380,750 (+43.06%) | Filing History |
| 2026-08-10 4:44 pm Sale | 2026-08-06 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 3,074,853 6.400% | -563,034 (-15.48%) | Filing History |
| 2026-08-05 9:08 pm Purchase | 2026-07-27 | 13D | YARROW BIOSCIENCE, INC. YARW | ORBIMED ADVISORS LLC | 266,306 9.970% | 266,306 (New Position) | Filing History |
| 2026-07-29 6:42 pm Purchase | 2026-07-27 | 13D | SCRIBE THERAPEUTICS INC SCTX | ORBIMED ADVISORS LLC | 1,348,825 7.200% | 1,348,825 (New Position) | Filing History |
| 2026-07-20 9:32 pm Unchanged | 2026-07-16 | 13D | Q32 BIO INC QTTB | ORBIMED ADVISORS LLC | 4,127,987 13.900% | 0 (Unchanged) | Filing History |
| 2026-06-24 7:15 pm Sale | 2026-06-22 | 13D | ENLIVEN THERAPEUTICS INC ELVN | ORBIMED ADVISORS LLC | 6,774,507 9.500% | -860,123 (-11.27%) | Filing History |
| 2026-06-17 7:41 pm Sale | 2026-06-15 | 13D | ENLIVEN THERAPEUTICS INC ELVN | ORBIMED ADVISORS LLC | 7,634,630 10.930% | -283,533 (-3.58%) | Filing History |
| 2026-06-15 6:10 pm Purchase | 2026-06-11 | 13D | SHATTUCK LABS INC STTK | ORBIMED ADVISORS LLC | 9,021,127 9.990% | 2,715,000 (+43.05%) | Filing History |